Cancer Biology (parallel) PhD Projects, Programmes & Scholarships

We have 6 Cancer Biology (parallel) PhD Projects, Programmes & Scholarships

Design and synthesis of next-generation antibody drug conjugates to target homologous recombination deficient cancers

University of Strathclyde Department of Pure and Applied Chemistry

Background. Antibody-drug conjugates (ADCs) offer a powerful strategy for the cell-selective delivery of therapeutics, while minimizing off-target interactions associated with the drug payload. Read more

Supervisors: Prof G Burley, Dr Z Rattray

3 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Using single cell transcriptomic and blood proteomic data to understand how pancreatic cancer causes diabetes and to find ways to detect the cancer earlier

University of Liverpool Department of Molecular and Clinical Cancer Medicine

Pancreatic cancer is the deadliest of the common cancers. Five-year survival remains low at 12%. Sadly for 80% of patients, by the time their cancer is diagnosed it has spread to distant organs making them ineligible for potentially curative surgery. Read more

Supervisor: Prof E Costello

23 May 2024 PhD Research Project Self-Funded PhD Students Only

More Details

Preclinical testing of collagen synthesis inhibitors for fibrotic disease

University of Liverpool Institute of Ageing and Chronic Disease Department of Musculoskeletal Biology

Fibrotic disease is characterised by an excessive accumulation of collagen within tissues, which then impedes tissue function. Organ fibrosis specifically kidney fibrosis, liver fibrosis, cardiac fibrosis and lung fibrosis have limited treatment options, pose a huge clinical burden and are life-limiting diseases. Read more

Supervisor: Dr EG Laird

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Development of chemical tools and bioactive compounds to explore the importance of enzyme activity in cancer diseases

University of Bradford Faculty of Life Sciences

Diversity-oriented synthesis (DOS) is a modern chemical methodology, which aims to synthesise small molecules that cover new chemical space with the possibility of finding unexplored biological targets or pathways that may be important for disease progression. Read more

Supervisors: Prof K Pors, Dr V Vangala

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Understanding centrosome assembly in healthy and cancerous tissue with imaging

University of Leicester Molecular and Cell Biology

This is an opportunity for a scientist to join the lab of Dr Robert Mahen in the Department of Molecular & Cell Biology at the University of Leicester. Read more

Supervisor: Dr R Mahen

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Investigating WSB-1 as a prognostic marker and therapeutic target in urogenital cancers

The University of Manchester Faculty of Biology, Medicine and Health

Prostate cancer (PCa) is the commonest cancer diagnosed in men, with 5-year survival rates of 60% in those with advanced disease. Read more

Supervisors: Dr IP Monteiro dos Santos Pires, Prof AC Choudhury

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

We have 6 Cancer Biology (parallel) PhD Projects, Programmes & Scholarships

Cancer Biology (parallel) PhD Projects, Programmes & Scholarships

We have 6 Cancer Biology (parallel) PhD Projects, Programmes & Scholarships

Design and synthesis of next-generation antibody drug conjugates to target homologous recombination deficient cancers

Using single cell transcriptomic and blood proteomic data to understand how pancreatic cancer causes diabetes and to find ways to detect the cancer earlier

Preclinical testing of collagen synthesis inhibitors for fibrotic disease

Development of chemical tools and bioactive compounds to explore the importance of enzyme activity in cancer diseases

Understanding centrosome assembly in healthy and cancerous tissue with imaging

Investigating WSB-1 as a prognostic marker and therapeutic target in urogenital cancers

Select your nearest city

Do you want hassle-free information and advice?